Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets

Eur J Pharmacol. 1995 Feb 15;288(3):373-7. doi: 10.1016/0922-4106(95)90051-9.

Abstract

The serotonin uptake inhibitors sertraline, paroxetine and fluoxetine were compared with imipramine and the calmodulin antagonists N-(6-aminohexyl)-5-chloro-1-naphthalene-sulfonamide (W-7) and calmidazolium, for their effects on intracellular Ca2+ mobilization in human platelets. All serotonin uptake inhibitors and calmodulin antagonists augmented thrombin-mediated increases in intracellular Ca2+. Sertraline, calmidazolium and W-7 also caused large dose-dependent increases in baseline levels of intracellular Ca2+. There was a rough correlation between the ability to elevate intracellular Ca2+ and potencies for inhibition of calmodulin. Neomycin, an inhibitor of inositol trisphosphate (IP3) generation, significantly inhibited the effects of sertaline. This is consistent with a role of IP3 and calmodulin in the effects of these drugs.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • 1-Naphthylamine / analogs & derivatives
  • 1-Naphthylamine / pharmacology
  • Blood Platelets / drug effects*
  • Blood Platelets / metabolism
  • Calcium / metabolism*
  • Calmodulin / pharmacology
  • Cells, Cultured
  • Fluoxetine / pharmacology
  • Humans
  • Imipramine / pharmacology
  • Paroxetine / pharmacology
  • Selective Serotonin Reuptake Inhibitors / pharmacology*
  • Sertraline

Substances

  • Calmodulin
  • Serotonin Uptake Inhibitors
  • Fluoxetine
  • Paroxetine
  • 1-Naphthylamine
  • Imipramine
  • Sertraline
  • Calcium